Daniela Frezzetti

4.5k total citations
18 papers, 613 citations indexed

About

Daniela Frezzetti is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Daniela Frezzetti has authored 18 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Daniela Frezzetti's work include Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related molecular mechanisms research (4 papers). Daniela Frezzetti is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related molecular mechanisms research (4 papers). Daniela Frezzetti collaborates with scholars based in Italy, Sweden and Malaysia. Daniela Frezzetti's co-authors include Nicola Normanno, Antonella De Luca, Marianna Gallo, Monica R. Maiello, Amelia D’Alessio, Nicoletta Chicchinelli, Claudia Esposito, Gabriella De Vita, Roberto Di Lauro and Cristin Roma and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Daniela Frezzetti

18 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Frezzetti Italy 13 358 266 175 110 59 18 613
Kang‐Lai Wei China 13 441 1.2× 325 1.2× 202 1.2× 148 1.3× 64 1.1× 27 680
Yizhi Zhan China 13 411 1.1× 241 0.9× 131 0.7× 84 0.8× 126 2.1× 18 621
Zhe Yang China 15 407 1.1× 280 1.1× 135 0.8× 101 0.9× 81 1.4× 42 656
Miaoxin Zhu China 11 471 1.3× 316 1.2× 159 0.9× 83 0.8× 57 1.0× 16 688
Marina Domingo‐Vidal United States 11 417 1.2× 390 1.5× 172 1.0× 57 0.5× 89 1.5× 16 653
Fu-Ju Chou United States 17 356 1.0× 233 0.9× 116 0.7× 228 2.1× 73 1.2× 22 682
Xiulan Zheng China 13 397 1.1× 308 1.2× 148 0.8× 276 2.5× 67 1.1× 14 637
Monika Świerczewska Poland 16 340 0.9× 228 0.9× 345 2.0× 121 1.1× 97 1.6× 31 712
Parker L. Sulkowski United States 9 487 1.4× 211 0.8× 122 0.7× 89 0.8× 82 1.4× 10 681

Countries citing papers authored by Daniela Frezzetti

Since Specialization
Citations

This map shows the geographic impact of Daniela Frezzetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Frezzetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Frezzetti more than expected).

Fields of papers citing papers by Daniela Frezzetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Frezzetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Frezzetti. The network helps show where Daniela Frezzetti may publish in the future.

Co-authorship network of co-authors of Daniela Frezzetti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Frezzetti. A scholar is included among the top collaborators of Daniela Frezzetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Frezzetti. Daniela Frezzetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Abate, Riziero Esposito, Raffaella Pasquale, Alessandra Sacco, et al.. (2024). Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative. Journal for ImmunoTherapy of Cancer. 12(2). e007800–e007800. 3 indexed citations
2.
Frezzetti, Daniela, Laura Marra, Rosa Camerlingo, et al.. (2024). The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells. International Journal of Molecular Sciences. 25(9). 4844–4844. 1 indexed citations
3.
Gallo, Marianna, Marianeve Carotenuto, Daniela Frezzetti, et al.. (2022). The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells. Cancers. 14(7). 1851–1851. 5 indexed citations
4.
Roma, Cristin, Alessandra Sacco, Laura Forgione, et al.. (2022). Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics. Diagnostics. 12(8). 1956–1956. 4 indexed citations
5.
Abate, Riziero Esposito, Daniela Frezzetti, Monica R. Maiello, et al.. (2020). Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls. Cancers. 12(12). 3804–3804. 35 indexed citations
6.
Rachiglio, Anna Maria, Matilde Lambiase, Francesca Fenizia, et al.. (2019). Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents. Cancers. 11(6). 859–859. 31 indexed citations
7.
Gallo, Marianna, et al.. (2019). The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells. Expert Review of Molecular Diagnostics. 19(8). 683–694. 13 indexed citations
8.
Luca, Antonella De, Monica R. Maiello, Amelia D’Alessio, et al.. (2018). Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer. Expert Opinion on Drug Metabolism & Toxicology. 14(9). 891–900. 20 indexed citations
9.
Gallo, Marianna, Daniela Frezzetti, Cristin Roma, et al.. (2018). RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells. Oncotarget. 9(25). 17543–17553. 25 indexed citations
10.
Luca, Antonella De, Daniela Frezzetti, Marianna Gallo, & Nicola Normanno. (2017). FGFR-targeted therapeutics for the treatment of breast cancer. Expert Opinion on Investigational Drugs. 26(3). 303–311. 27 indexed citations
11.
Gallo, Marianna, Daniela Frezzetti, Nicola Normanno, & Antonella De Luca. (2017). Abstract 4343: Effects of the co-expression of RANTES and IL-6 on the transformed phenotype of breast cancer cells. Cancer Research. 77(13_Supplement). 4343–4343. 1 indexed citations
12.
Frezzetti, Daniela, Marianna Gallo, Monica R. Maiello, et al.. (2017). VEGF as a potential target in lung cancer. Expert Opinion on Therapeutic Targets. 21(10). 959–966. 186 indexed citations
13.
Iervolino, Anna, Francesco Trepiccione, Manuela Spagnuolo, et al.. (2015). Selective Dicer Suppression in the Kidney Alters GSK3β/β-Catenin Pathways Promoting a Glomerulocystic Disease. PLoS ONE. 10(3). e0119142–e0119142. 24 indexed citations
14.
Frezzetti, Daniela, Marianna Gallo, Cristin Roma, et al.. (2015). Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells. Journal of Cellular Physiology. 231(7). 1514–1521. 43 indexed citations
15.
Luca, Antonella De, Amelia D’Alessio, Monica R. Maiello, et al.. (2014). Vandetanib as a potential treatment for breast cancer. Expert Opinion on Investigational Drugs. 23(9). 1295–1303. 12 indexed citations
16.
Luca, Antonella De, Cristin Roma, Marianna Gallo, et al.. (2014). RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells. Oncotarget. 5(21). 10518–10528. 16 indexed citations
17.
Frezzetti, Daniela, Gaetano Calı̀, Lucio Nitsch, et al.. (2011). The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function. PLoS ONE. 6(11). e27648–e27648. 50 indexed citations
18.
Frezzetti, Daniela, Marta De Menna, Pietro Zoppoli, et al.. (2010). Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene. 30(3). 275–286. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kang‐Lai Wei Breakdown of academic impact, for papers by Yizhi Zhan Breakdown of academic impact, for papers by Zhe Yang Breakdown of academic impact, for papers by Miaoxin Zhu Breakdown of academic impact, for papers by Marina Domingo‐Vidal Breakdown of academic impact, for papers by Fu-Ju Chou Breakdown of academic impact, for papers by Xiulan Zheng Breakdown of academic impact, for papers by Monika Świerczewska Breakdown of academic impact, for papers by Parker L. Sulkowski
Rankless by CCL
2026